THURSDAY, November
16
10.00 - 10.30 Welcome addresses and presentation
of the course
S. Iacobelli
(Chieti, Italy) 
go to slides
AR. Bianco (Naples, Italy)
10.30 - 12.15
Brain and bone
metastases
Brain metastases: current and future treatment
options
(A. Fabi,
Rome, Italy) go to slides
Bone metastasis in
breast cancer: Molecular pathogenesis.
(M. Longo,
L’Aquila, Italy) go to slides
From administration
to side effects: choosing the ideal bisphosphonate
(C. Ripamonti,
Milan, Italy)
12.15
- 13.00 Aromatase inhibitors
A turning point in adjuvant therapy: optimizing
use of aromatase inhibitors
(P. Pronzato,
La Spezia, Italy) go to slides
13.00 – 14.00
Lunch
14.30 - 15.30
HRT
HRT: benefits and risks
(A. Gadducci, Pisa,
Italy)
14.45– 16.15 Breast Cancer
Prognosis
Prognostic value
of occult breast cancer cells in blood and bone
marrow
(G. Wiedswang,
Oslo, Norway) go to slides
Gene-expression signatures
for breast cancer prognosis, site of metastasis,
and therapy resistance
(J.A. Foekens,
Rotterdam, The Netherlands) go to slides
16.15– 17.00 Clinical trials in breast cancer
Clinical trials in breast cancer in Italy: The "Gruppo Italiano Mammella (GIM)"
(L. Del Mastro, Genoa, Italy)go to slides
FRIDAY, November 17
9.00 - 12.00
- Round Table
“Therapeutic Antibodies and Multitargeted
Tyrosine Kinase Inhibitors”
(Chairpersons:
D. Slamon, Los Angeles, USA – A. Ullrich,
Martinsried, Germany)
Herceptin and SUTENT
(Sunitinib) : From Mono-Specific to Multi-Targeted
Cancer Therapies
(A Ullrich,
Martinsried, Germany) go to slides
Update on HER-2 Directed
Therapy
(D. Slamon,
Los Angeles, USA)go to slides
Bevacizumab
Antiangiogenic therapy for breast cancer - where
do we stand?
(F. Ciardiello,
Naples, Italy) go to slides
Lapatinib
(P.F. Conte,
Modena, Italy)go to slides
12.00 –12.30
General Discussion &
Conclusion
(A.R. Bianco, Naples,
Italy)
| A.R.
Bianco
University Federico
II
Naples, Italy
F.
Ciardiello
II University
Naples, Italy
P.F.
Conte
University of Modena
and Reggio Emilia
Modena, Italy
L. Del Mastro
National Cancer Research Institute
Genoa, Italy
A.
Fabi
Regina Elena National
Cancer Institute
Rome, Italy
J.A.
Foekens
Josephine Nefkens
Institute
Rotterdam, The Netherlands
A.
Gadducci
Santa Chiara Hospital
Pisa, Italy
|
S.
Iacobelli
University G. D'Annunzio
Chieti, Italy
M. Longo
University of L’Aquila
L'Aquila, Italy
P.
Pronzato
Sant’Andrea
Hospital
La Spezia, Italy
C. Ripamonti
National Cancer Institute
Milan, Italy
D.
Slamon
UCLA
Los Angeles, USA
A.
Ullrich
Max-Plank Institute
Martinsried, Germany
G.
Wiedswang
Ulleval University
Hospital
Oslo, Norway |
